Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Genotype of Cytochrome P450 (CYP2C9) on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery

NCT02450487 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT02450487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02450487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Genotype of Cytochrome P450 (CYP2C9) on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery
Lead sponsor
University of Sao Paulo
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2012
Completion date
December 31, 2015
Enrollment
105 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cytochrome p450 cyp2c9 enzyme deficiency, impacted third molar tooth, other surgical procedures, pain